Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seroquel vs Risperidone in Schizophrenia with Comorbid Substance Abuse
NCT00208143Phase 4Completed
- Sponsor
- Creighton University
- Start
- Nov 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of quetiapine in schizophrenia, schizoaffective disorder, cocaine dependence and 1 more (2 arms), sponsored by Creighton University. Primary endpoint: 50% or greater decrease in the drug use determined by the Time Line Follow Back method versus baseline at 24 weeks. Started Nov 2003; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophreniaschizoaffective disordercocaine dependenceamphetamine dependence
Beyond the preview
Go deeper on NCT00208143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00208143.